Clinical trials: Retroperitoneal Fibrosis
Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis
National Registry of Rare Kidney Diseases
The goal of this National Registry is to is to collect information from patients with rare kidney diseases, so that it that can be used for research.
- Conditions
- Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, AHL Amyloidosis, AL Amyloidosis
- Trial name
- RaDaR (NCT06065852)
- Where
- United Kingdom
- Volunteers
- 35,000 people
- Sponsor
- UK Kidney Association
Retroperitoneal Fibrosis
Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal Fibrosis
Idiopathic retroperitoneal fibrosis (IRF) is a rare disease characterised by the presence of a retroperitoneal periaortic fibro-inflammatory tissue which may entrap the ureters and cause renal failure.
- Trial name
- NCT00440349
- Testing
- Tamoxifen, Prednisone
- Where
- Italy
- Volunteers
- 38 people
- Sponsor
- University of Parma
Retroperitoneal Sarcoma, Retroperitoneal Fibrosis
Distinguishing Retroperitoneal Fibrosis and Sarcoma from Other Retroperitoneal Diseases Via Radiomics
A retrospective study utilizing archived CT scans of patients diagnosed with retroperitoneal fibrosis, sarcoma or other malignancies (i.e.
- Trial name
- NCT06741423
- Testing
- Radiomics Algortihm
- Where
- 2 sites in China, Germany
- Volunteers
- 600 people
- Sponsor
- Heidelberg University